» Articles » PMID: 38466402

Long-term Survival and Functional Outcomes of Critically Ill Patients with Hematologic Malignancies: a Canadian Multicenter Prospective Study

Abstract

Purpose: Patients with hematologic malignancy (HM) commonly develop critical illness. Their long-term survival and functional outcomes have not been well described.

Methods: We conducted a prospective, observational study of HM patients admitted to seven Canadian intensive care units (ICUs) (2018-2020). We followed survivors at 7 days, 6 months and 12 months following ICU discharge. The primary outcome was 12-month survival. We evaluated functional outcomes at 6 and 12 months using the functional independent measure (FIM) and short form (SF)-36 as well as variables associated with 12-month survival.

Results: We enrolled 414 patients including 35% women. The median age was 61 (interquartile range, IQR: 52-69), median Sequential Organ Failure Assessment (SOFA) score was 9 (IQR: 6-12), and 22% had moderate-severe frailty (clinical frailty scale [CFS] ≥ 6). 51% had acute leukemia, 38% lymphoma/multiple myeloma, and 40% had received a hematopoietic stem cell transplant (HCT). The most common reasons for ICU admission were acute respiratory failure (50%) and sepsis (40%). Overall, 203 (49%) were alive 7 days post-ICU discharge (ICU survivors). Twelve-month survival of the entire cohort was 21% (43% across ICU survivors). The proportion of survivors with moderate-severe frailty was 42% (at 7 days), 14% (6 months), and 8% (12 months). Median FIM at 7 days was 80 (IQR: 50-109). Physical function, pain, social function, mental health, and emotional well-being were below age- and sex-matched population scores at 6 and 12 months. Frailty, allogeneic HCT, kidney injury, and cardiac complications during ICU were associated with lower 12- month survival.

Conclusions: 49% of all HM patients were alive at 7 days post-ICU discharge, and 21% at 12 months. Survival varied based upon hematologic diagnosis and frailty status. Survivors had important functional disability and impairment in emotional, physical, and general well-being.

Citing Articles

[The value of sequential organ failure assessment and its dynamic changes in predicting mortality in hematology intensive care unit].

Wang J, Zhang J, Zhang B, Cao Y, Guo Y, Yu P Zhonghua Xue Ye Xue Za Zhi. 2025; 46(1):31-38.

PMID: 40059679 PMC: 11886445. DOI: 10.3760/cma.j.cn121090-20241130-00510.


Clinical characteristics and prognostic factors of sepsis in patients with malignancy.

Hong G, Ju H, Oh D, Lee S, Park M, Lee H Sci Rep. 2025; 15(1):7078.

PMID: 40016348 DOI: 10.1038/s41598-025-87457-y.


Prognostic indicators in intensive care unit oncology patients: bridging short-term and long-term survival.

Atallah F, Rosa R, Puxty K Crit Care Sci. 2024; 36:e20240262en.

PMID: 39699392 PMC: 11634240. DOI: 10.62675/2965-2774.20240262-en.


Long-term outcomes of critically ill patients with hematological malignancies: what is the impact of the coronavirus disease 2019 pandemic? Author's reply.

Munshi L, Dumas G, Mehta S Intensive Care Med. 2024; 50(11):1944.

PMID: 39352486 DOI: 10.1007/s00134-024-07614-1.


Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies.

Bredin S, Decroocq J, Devautour C, Charpentier J, Vigneron C, Pene F Ann Intensive Care. 2024; 14(1):143.

PMID: 39259434 PMC: 11390996. DOI: 10.1186/s13613-024-01372-5.


References
1.
Ferreyro B, Scales D, Wunsch H, Cheung M, Gupta V, Saskin R . Critical illness in patients with hematologic malignancy: a population-based cohort study. Intensive Care Med. 2021; 47(10):1104-1114. DOI: 10.1007/s00134-021-06502-2. View

2.
Azoulay E, Soares M, Lengline E . Preempting critical care services for patients with hematological malignancies. Intensive Care Med. 2021; 47(10):1140-1143. DOI: 10.1007/s00134-021-06521-z. View

3.
Darmon M, Bourmaud A, Georges Q, Soares M, Jeon K, Oeyen S . Changes in critically ill cancer patients' short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med. 2019; 45(7):977-987. DOI: 10.1007/s00134-019-05653-7. View

4.
Scales D, Thiruchelvam D, Kiss A, Sibbald W, Redelmeier D . Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care. 2008; 12(3):R77. PMC: 2481474. DOI: 10.1186/cc6923. View

5.
Azoulay E, Thiery G, Chevret S, Moreau D, Darmon M, Bergeron A . The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore). 2004; 83(6):360-370. DOI: 10.1097/01.md.0000145370.63676.fb. View